Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "talent"

370 News Found

India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap
Biopharma | April 13, 2026

India Pharma 2026 underscores policy momentum, innovation push, and self-reliance roadmap

The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness


Dr. Jitendra Singh urges industry to step up R&D collaboration
R&D | April 09, 2026

Dr. Jitendra Singh urges industry to step up R&D collaboration

Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India


Lupin secures global Great Place To Work certification for 2026-27
News | April 07, 2026

Lupin secures global Great Place To Work certification for 2026-27

Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development


Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer
People | April 06, 2026

Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer

Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation


Max Healthcare allots 57,461 equity shares under ESOP 2022
Hospitals | April 05, 2026

Max Healthcare allots 57,461 equity shares under ESOP 2022

Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees


Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students
Biotech | April 03, 2026

Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students

Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship


Biogen to buy Apellis Pharmaceuticals for $5.6B in rare disease and immunology push
News | April 02, 2026

Biogen to buy Apellis Pharmaceuticals for $5.6B in rare disease and immunology push

The acquisition brings two commercialized, differentiated medicines—EMPAVELI and SYFOVRE —to Biogen’s growth portfolio


Shreehas Tambe appointed CEO & Managing Director of Biocon
People | March 28, 2026

Shreehas Tambe appointed CEO & Managing Director of Biocon

Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited


Zealand Pharma launches major US research hub in Cambridge, Massachusetts
R&D | March 26, 2026

Zealand Pharma launches major US research hub in Cambridge, Massachusetts

The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities


IIT Roorkee unveils cutting-edge molecular medicine facility
R&D | March 19, 2026

IIT Roorkee unveils cutting-edge molecular medicine facility

The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics